Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2000
03/09/2000WO2000012483A1 Triptolide prodrugs having high aqueous solubility
03/09/2000WO2000012479A1 2-oxo-2h-quinoline derivatives
03/09/2000WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012467A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012101A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
03/09/2000WO2000012089A1 Novel angiogenesis inhibitors
03/09/2000WO2000012085A1 Ascorbate-isoquercetin compositions
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000WO2000012076A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/09/2000WO2000012074A2 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000WO2000012067A1 Novel pharmaceutical salt form
03/09/2000WO2000012061A1 Synthetic tear fluid
03/09/2000WO2000011926A2 Method for the preparation of citalopram
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999059524A3 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342901A1 Triptolide prodrugs having high aqueous solubility
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342230A1 2-oxo-2h-quinoline derivatives
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2341522A1 Novel pharmaceutical salt form
03/09/2000CA2341409A1 Novel angiogenesis inhibitors
03/09/2000CA2340975A1 Synthetic tear fluid
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2339539A1 Modulating multiple lineage kinase proteins
03/09/2000CA2339189A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
03/08/2000EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission
03/08/2000EP0984012A2 Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
03/08/2000EP0983995A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
03/08/2000EP0983994A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds
03/08/2000EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
03/08/2000EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases
03/08/2000EP0983304A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
03/08/2000EP0983275A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
03/08/2000EP0983259A1 Tocopherol esters and their cosmetic and pharmaceutical uses
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983256A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
03/08/2000EP0983251A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
03/08/2000EP0983249A1 Processes and intermediates for preparing substituted indazole derivatives
03/08/2000EP0983235A2 Leukotriene b 4? derivatives, in particular oximo-ltb 4? antagonists
03/08/2000EP0983234A1 Leukotriene b 4? derivatives, in particular 7-methylcyclohexyl-ltb 4? antagonists
03/08/2000EP0983228A1 Protease inhibitors
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983073A1 Ophthalmic compositions containing a divalent salt and a non steroidal anti-inflammatory drugs as a precipitate
03/08/2000EP0983064A1 PYRROLES AS sPLA2 INHIBITORS
03/08/2000EP0983059A1 Process for making flurbiprofen lozenges
03/08/2000EP0983058A1 Medicinal aerosol products
03/08/2000EP0982991A1 Beta lactams as antiproliferative agents
03/08/2000EP0784623B1 Naphthyridine derivatives
03/08/2000EP0696287B1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246848A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
03/08/2000CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/08/2000CN1246475A Corticotropin release factors antagonistic agent
03/08/2000CN1050132C Ginkgotide derivatives
03/08/2000CN1050129C Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000US6034256 Substituted benzopyran derivatives for the treatment of inflammation
03/07/2000US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists
03/07/2000US6034136 Certain cyclic thio substituted acylaminoacid amide derivatives
03/07/2000US6034127 Amidino protease inhibitors
03/07/2000US6034122 Combined use of diclofenac and tribenoside to treat osteoarthritis
03/07/2000US6034107 5-Substituted picolinic acid compounds and their production process
03/07/2000US6034096 Compounds with anti-inflammatory and immunosuppressive activities
03/07/2000US6034094 Pharmaceutically useful 3,4-dihydroisoquinoline
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034057 Cyclic octapeptide; antiarthritic agent
03/07/2000US6034056 Cyclic peptides; antiarthritic agents
03/07/2000US6033910 Antisense inhibition of MAP kinase kinase 6 expression
03/07/2000US6033873 Cytokine suppressive anti-inflammatory drug (csaid) binding proteins csbp.beta.
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011174A1 Human il-1 epsilon dna and polypeptides
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000010999A2 New compounds
03/02/2000WO2000010997A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010981A1 Quinazoline derivatives
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010611A2 Drug targeting
1 ... 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 ... 1272